Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
fluorotelomer alcohols [Supplementary Concept]
structure given in first source
Date introduced: March 23, 1982
2-(N-ethylperfluorooctanesulfonamido)ethyl alcohol [Supplementary Concept]
Date introduced: September 21, 2001
tebuconazole [Supplementary Concept]
Date introduced: June 3, 1994
1-(3-chlorophenyl)-2-(4-hydroxyphenyl)-1-methyl-2- (2-pyridine)ethanol [Supplementary Concept]
RN given refers to cpd with unspecified isomeric designation
Date introduced: January 1, 1976
1-(3,4-dihydroxyphenyl)-2-(3-(4-carbamylphenyl)-1-methylpropylamino)ethanol [Supplementary Concept]
GP-2-114 is a 50:50 mixture of (RR)- and (RS)- isomers; do not confuse with GP 128 (thrombospondin); structure in first source
Date introduced: July 8, 1994
4-(4-chlorophenyl)-3,7,7-trimethyl-1-(2-(4-nitrobenzoyl)ethyl)-4,7,8,9-tetrahydro-1H-pyrazolo(3,4-b)quinolin-5(6H)-one-ethanol [Supplementary Concept]
structure in first source
Date introduced: January 12, 2002
trans-2-(((3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl)methylsulfanyl)ethanol [Supplementary Concept]
Date introduced: August 7, 2006
2-(3-methoxy-4-hydroxyphenyl)ethanol-O-arabinopyranosyl-(1-2)-rhamnopyranosyl-(1-3)-glucopyranoside [Supplementary Concept]
has hepatoprotective activity; isolated from Leonurus japonicus; structure in first source
Date introduced: May 20, 2012
2-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl amino)ethanol [Supplementary Concept]
a water-soluble highly selective sphingosine-1 phosphate (S1P1) agonist; structure in first source
Date introduced: November 17, 2008
N(4)-methyl-N(4)-(2-methylphenyl)-1H-pyrazolo(3,4-d)pyrimidine-4,6-diamine-ethanol-hydrazine [Supplementary Concept]
Date introduced: September 16, 2009
1-(4-(4-(4,6-dimethyl(1,3,5)triazin-2-yl)2,6,-dimethylpiperazin-1-yl)pyrimidin-2-yl)ethanol [Supplementary Concept]
a sorbitol dehydrogenase inhibitor; structure in first source
Date introduced: October 16, 2002
2-(4-methyl-1,3-thiazol-5-yl)ethanol [Supplementary Concept]
the thiazole portion of thiamine; imparts flavor to cooked meats; RN given is for parent cpd; structure
Date introduced: January 1, 1974
2-(3-methoxyl-4-hydroxyphenyl)ethanol-O-rhamnopyranosyl-(1-3) (glucopyranosyl-(1-6))-glucopyranoside [Supplementary Concept]
1-(4-(3R,5S-dimethyl-4-(4-methyl)-(1,3,5-triazin-2-yl)-piperazin-1-yl)-(1,3,5)triazin-2-yl)-(R)-ethanol [Supplementary Concept]
Date introduced: May 24, 2004
1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo(4.4.0)deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol [Supplementary Concept]
Adrenergic beta-Agonist; structure in first source
Date introduced: July 21, 2009
LU 52396 [Supplementary Concept]
Date introduced: July 12, 1995
HC Blue No. 2 [Supplementary Concept]
Date introduced: November 16, 1987
2-(4-(2-fluoro-5-(3-(6-methylpyridine-2-yl)-1H-pyrazol-4-yl)phenyl)pyrazol-1-yl)ethanol [Supplementary Concept]
inhibits activin receptor-like kinase 5; structure in first source
Date introduced: January 25, 2015
3,4-dihydroxyphenylethanol [Supplementary Concept]
serotonin metabolite; structure
2-(4-(3-quinolin-6-ylmethyl-3H-(1,2,3)triazolo(4,5-b)pyrazin-5-yl)pyrazol-1-yl)ethanol [Supplementary Concept]
a cMet kinase inhibitor; structure in first source
Date introduced: June 12, 2011